These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26209879)

  • 1. QSAR study and conformational analysis of 4-arylthiazolylhydrazones derived from 1-indanones with anti-Trypanosoma cruzi activity.
    Noguera GJ; Fabian LE; Lombardo E; Finkielsztein L
    Eur J Pharm Sci; 2015 Oct; 78():190-7. PubMed ID: 26209879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of some novel 1-indanone thiazolylhydrazone derivatives as anti-Trypanosoma cruzi agents.
    Caputto ME; Ciccarelli A; Frank F; Moglioni AG; Moltrasio GY; Vega D; Lombardo E; Finkielsztein LM
    Eur J Med Chem; 2012 Sep; 55():155-63. PubMed ID: 22840495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of 4-arylthiazolylhydrazones derived from 1-indanones as Trypanosoma cruzi squalene epoxidase inhibitors by molecular simulations.
    Noguera GJ; Fabian LE; Lombardo E; Finkielsztein LM
    Org Biomol Chem; 2018 Nov; 16(44):8525-8536. PubMed ID: 30357228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound profiling and 3D-QSAR studies of hydrazone derivatives with activity against intracellular Trypanosoma cruzi.
    Costa LB; Cardoso MV; de Oliveira Filho GB; de Moraes Gomes PA; Espíndola JW; de Jesus Silva TG; Torres PH; Silva Junior FP; Martin J; de Figueiredo RC; Leite AC
    Bioorg Med Chem; 2016 Apr; 24(8):1608-18. PubMed ID: 26964673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
    Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
    Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents.
    Caputto ME; Fabian LE; Benítez D; Merlino A; Ríos N; Cerecetto H; Moltrasio GY; Moglioni AG; González M; Finkielsztein LM
    Bioorg Med Chem; 2011 Nov; 19(22):6818-26. PubMed ID: 22000947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New potent 5-substituted benzofuroxans as inhibitors of Trypanosoma cruzi growth: quantitative structure-activity relationship studies.
    Aguirre G; Boiani L; Boiani M; Cerecetto H; Di Maio R; González M; Porcal W; Denicola A; Piro OE; Castellano EE; Sant'Anna CM; Barreiro EJ
    Bioorg Med Chem; 2005 Dec; 13(23):6336-46. PubMed ID: 16202608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-based design, synthesis, and experimental evaluation of novel benzofuroxan derivatives as anti-Trypanosoma cruzi agents.
    Jorge SD; Palace-Berl F; Mesquita Pasqualoto KF; Ishii M; Ferreira AK; Berra CM; Bosch RV; Maria DA; Tavares LC
    Eur J Med Chem; 2013 Jun; 64():200-14. PubMed ID: 23644203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico molecular docking studies of new potential 4-phthalazinyl-hydrazones on selected Trypanosoma cruzi and Leishmania enzyme targets.
    Romero AH; López SE
    J Mol Graph Model; 2017 Sep; 76():313-329. PubMed ID: 28763686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors.
    Fernández M; Varela J; Correia I; Birriel E; Castiglioni J; Moreno V; Costa Pessoa J; Cerecetto H; González M; Gambino D
    Dalton Trans; 2013 Sep; 42(33):11900-11. PubMed ID: 23787783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, leishmanicidal, trypanocidal and cytotoxic activity of quinoline-hydrazone hybrids.
    Coa JC; Castrillón W; Cardona W; Carda M; Ospina V; Muñoz JA; Vélez ID; Robledo SM
    Eur J Med Chem; 2015 Aug; 101():746-53. PubMed ID: 26218652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity against Trypanosoma cruzi of substituted 1,4-naphthoquinones.
    Olímpio da Silva A; da Silva Lopes R; Vieira de Lima R; Santos Suniga Tozatti C; Marques MR; de Albuquerque S; Beatriz A; Pires de Lima D
    Eur J Med Chem; 2013 Feb; 60():51-6. PubMed ID: 23279867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity on Trypanosoma cruzi, erythrocytes lysis and biologically relevant physicochemical properties of Pd(II) and Pt(II) complexes of thiosemicarbazones derived from 1-indanones.
    Santos D; Parajón-Costa B; Rossi M; Caruso F; Benítez D; Varela J; Cerecetto H; González M; Gómez N; Caputto ME; Moglioni AG; Moltrasio GY; Finkielsztein LM; Gambino D
    J Inorg Biochem; 2012 Dec; 117():270-6. PubMed ID: 23063173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-dependent 4D-QSAR analysis of peptidemimetic inhibitors of Trypanosoma cruzi trypanothione reductase with receptor-based alignment.
    da Rocha Pita SS; Albuquerque MG; Rodrigues CR; Castro HC; Hopfinger AJ
    Chem Biol Drug Des; 2012 May; 79(5):740-8. PubMed ID: 22269140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
    Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action.
    Vieites M; Smircich P; Guggeri L; Marchán E; Gómez-Barrio A; Navarro M; Garat B; Gambino D
    J Inorg Biochem; 2009 Oct; 103(10):1300-6. PubMed ID: 19361864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-Trypanosoma cruzi activity of derivatives from nor-lapachones and lapachones.
    da Silva Júnior EN; de Souza MC; Fernandes MC; Menna-Barreto RF; Pinto Mdo C; de Assis Lopes F; de Simone CA; Andrade CK; Pinto AV; Ferreira VF; de Castro SL
    Bioorg Med Chem; 2008 May; 16(9):5030-8. PubMed ID: 18378461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular modeling and QSAR study of suppressors of the growth of Trypanosoma cruzi epimastigotes.
    de Paula da Silva CH; Sanches SM; Taft CA
    J Mol Graph Model; 2004 Sep; 23(1):89-97. PubMed ID: 15331057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-leishmanial and anti-trypanosomal activities of 1,4-dihydropyridines: In vitro evaluation and structure-activity relationship study.
    Reimão JQ; Scotti MT; Tempone AG
    Bioorg Med Chem; 2010 Nov; 18(22):8044-53. PubMed ID: 20934347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.